21 CFR 522.1890

§ 522.1890 Prednisone suspension.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.1890, § 522.1890 Prednisone suspension, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87520
Permanent ID: ys:prov:87520@1
SHA-256: 129d29f2cfc518b61dc2f3949ad8813064da174001cc5bb0f5472edf19ffcc30

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of suspension contains 10 to 40 milligrams (mg) of prednisone. (b) Sponsor. See No. 000061 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Amount—(i) Horses. Administer 100 to 400 mg by intramuscular injection, repeating if necessary. (ii) Dogs and cats. Administer 0.25 to 1.0 mg per pound of body weight by intramuscular injection for 3 to 5 days or until a response is noted. Treatment may be continued with an orally administered dose. (2) Indications for use. It is used for conditions requiring an anti-inflammatory agent. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.